Structure, Physicochemical and Biological Properties of an Aqua (2,2′,2′′‐Nitrilotriacetato)‐oxidovanadium(IV) Salt with 4‐Methylpyridinium Cation

[1]  D. Wyrzykowski,et al.  Structural, physico-chemical and antioxidant characteristics of 2,2′-bipyridyl(iminodiacetato)oxidovanadium(IV) dihydrate , 2015 .

[2]  B. Yahaya,et al.  Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines , 2015, Oncology reports.

[3]  D. Wyrzykowski,et al.  Structure, physicochemical and biological properties of new complex salt of aqua-(nitrilotriacetato-N,O,O',O")-oxidovanadium(IV) anion with 1,10-phenanthrolinium cation. , 2015, Journal of inorganic biochemistry.

[4]  João Costa Pessoa,et al.  Vanadium and proteins: Uptake, transport, structure, activity and function , 2015 .

[5]  A. Salifoglou,et al.  The chemistry and biology of vanadium compounds in cancer therapeutics , 2015 .

[6]  R. Kazmierkiewicz,et al.  Structural self-organization of C60 and cisplatin in physiological solution. , 2015, Physical chemistry chemical physics : PCCP.

[7]  D. Wyrzykowski,et al.  Physicochemical properties of ternary oxovanadium(IV) complexes with oxydiacetate and 1,10-phenanthroline or 2,2′-bipyridine. Cytoprotective activity in hippocampal neuronal HT22 cells , 2015, BioMetals.

[8]  G. Sheldrick.  SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[9]  G. Sheldrick.  Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.

[10]  S. Etcheverry,et al.  Vanadium compounds in medicine , 2014, Coordination Chemistry Reviews.

[11]  D. Wyrzykowski,et al.  Physicochemical and Biological Properties of Oxovanadium(IV), Cobalt(II) and Nickel(II) Complexes with Oxydiacetate Anions , 2014, Biological Trace Element Research.

[12]  D. Wyrzykowski,et al.  Analytical Methods for Determination of Reactive Oxygen Species , 2014 .

[13]  Z. Dvořák,et al.  Gold(I)-Triphenylphosphine Complexes with Hypoxanthine-Derived Ligands: In Vitro Evaluations of Anticancer and Anti-Inflammatory Activities , 2014, PloS one.

[14]  D. Wyrzykowski,et al.  Thermal properties of [Co(en)2Cl2]Cl in solid state. Cis–trans isomerization of the [Co(en)2Cl2]+ complex ion in methanol , 2014, Reaction Kinetics, Mechanisms and Catalysis.

[15]  D. Wyrzykowski,et al.  Cis-[Cr(C2O4)(pm)(OH2)2]+ Coordination Ion as a Specific Sensing Ion for H2O2 Detection in HT22 Cells , 2014, Molecules.

[16]  D. Rehder.  The future of/for vanadium. , 2013, Dalton transactions.

[17]  D. Wyrzykowski,et al.  Electrochemical and Biological Studies on Reactivity of [VO(oda)(H2O)2], [Co(oda)(H2O)2]·H2O, and [Ni(oda)­(H2O)3]·1.5H2O Towards Superoxide Free Radicals , 2013 .

[18]  S. Etcheverry,et al.  Spectroscopic Characterization of an Oxovanadium(IV) Complex of Oxodiacetic Acid and o-Phenanthroline. Bioactivity on Osteoblast-Like Cells in Culture , 2012, Biological Trace Element Research.

[19]  P. A. Lay,et al.  Metal-based anti-diabetic drugs: advances and challenges. , 2011, Dalton transactions.

[20]  T. Kiss,et al.  The speciation of vanadium in human serum , 2011 .

[21]  Zihua Hu,et al.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes. , 2011, Coordination chemistry reviews.

[22]  D. Gambino.  Potentiality of vanadium compounds as anti-parasitic agents , 2011 .

[23]  I. Uçar,et al.  Three forms of squaric acid with pyrazine and pyridine derivatives: an experimental and theoretical study , 2011 .

[24]  M. Valko,et al.  Advances in metal-induced oxidative stress and human disease. , 2011, Toxicology.

[25]  M. Makowski,et al.  Thermal behaviour of citric acid and isomeric aconitic acids , 2011 .

[26]  Dietrich Büsselberg,et al.  Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects , 2011, Cancers.

[27]  C. Freire,et al.  A DFT quantum mechanical study of 3-hydroxy-4-pyrone and 3-hydroxy-4-pyridinone based oxidovanadium(IV) complexes , 2011 .

[28]  J. Pessoa,et al.  Transport of therapeutic vanadium and ruthenium complexes by blood plasma components. , 2010, Current medicinal chemistry.

[29]  Lech Chmurzynski,et al.  A Novel Biosensor for Evaluation of Apoptotic or Necrotic Effects of Nitrogen Dioxide during Acute Pancreatitis in Rat , 2009, Sensors.

[30]  L. Lucia,et al.  General Spectroscopic Protocol to Obtain the Concentration of the Superoxide Anion Radical , 2009 .

[31]  J. McNeill,et al.  Vanadium treatment of type 2 diabetes: a view to the future. , 2009, Journal of inorganic biochemistry.

[32]  J. Berry,et al.  Diamagnetic Corrections and Pascal's Constants , 2008 .

[33]  D. Wyrzykowski,et al.  Synthesis and magnetic characteristics of new tetrachloroferrates(III) with 2-methylpyridinium, 3-methylpyridinium and 4-methylpyridinium cations: X-ray crystal structure of 4-methylpyridinium tetrachloroferrate(III) , 2007 .

[34]  K. Rahman.  Studies on free radicals, antioxidants, and co-factors , 2007, Clinical interventions in aging.

[35]  N. Okabe,et al.  Structures and DNA-binding and cleavage properties of ternary copper(II) complexes of glycine with phenanthroline, bipyridine, and bipyridylamine. , 2007, Chemical & pharmaceutical bulletin.

[36]  Katherine H Thompson,et al.  Vanadium in diabetes: 100 years from Phase 0 to Phase I. , 2006, Journal of inorganic biochemistry.

[37]  A. Srivastava,et al.  Insulino‐mimetic and anti‐diabetic effects of vanadium compounds , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[38]  Isabel Brandariz,et al.  Comparison of Several Calibration Procedures for Glass Electrodes in Proton Concentration , 2004 .

[39]  Jiuhui Liu,et al.  Synthesis and characterization of vanadium(IV)–M (M=Mn, Zn) and vanadium(IV)–Ln (Ln=La, Nd) complexes with nitrilotriacetate ligands: {(NH4)2[(VIVO)2(μ2-O)(nta)2M(H2O)4] · 2H2O}n and NH4[Ln(H2O)9][(VIVO)2 (μ2-O)(nta)2] , 2004 .

[40]  Agustín Galindo,et al.  Synthesis, molecular structure and properties of oxo-vanadium(IV) complexes containing the oxydiacetate ligand , 2003 .

[41]  R. Maurya,et al.  OXOVANADIUM(IV) COMPLEXES OF BIOINORGANIC AND INDUSTRIAL RELEVANCE: SYNTHESIS AND CHARACTERIZATION OF SOME OXOVANADIUM(IV) COMPLEXES INVOLVING SCHIFF BASES DERIVED FROM BIOLOGICALLY ACTIVE 4-BENZOYL-3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE AND CERTAIN AROMATIC AMINES , 2002 .

[42]  M. Bolte,et al.  Three hydrohalogenides of organic nitrogen bases , 1999 .

[43]  C. Rice-Evans,et al.  Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.

[44]  P. Gans,et al.  Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species , 1999 .

[45]  E. Tiekink,et al.  MONO- AND DINUCLEAR OXOVANADIUM(IV) COMPOUNDS CONTAINING VO(ONS) BASIC CORE : SYNTHESIS, STRUCTURE AND SPECTROSCOPIC PROPERTIES , 1997 .

[46]  P. Gans,et al.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. , 1996, Talanta.

[47]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[48]  G. Keserü,et al.  Pyridine-type complexes of transition-metal halides. III: Structural and thermal relationships among the cobalt(II) complexes with halide ions and 2-, 3-, and 4-Methylpyridine, the crystal structure of dibromotetrakis (3-methylpyridine)cobalt(II) , 1994 .

[49]  A. Powell,et al.  A New Type of Hexanuclear Iron(III) Hydroxo(oxo) Cluster , 1993 .

[50]  J. McNeill,et al.  Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. , 1992, Journal of medicinal chemistry.

[51]  M. C. Etter.  Encoding and decoding hydrogen-bond patterns of organic compounds , 1990 .

[52]  E. Ingier-Stocka,et al.  Thermal decomposition of [Co(NH3)6]Cl3 , 1989 .

[53]  J. Felcman,et al.  Complexes of oxovanadium(IV) with polyaminocarboxylic acids. , 1983, Talanta.

[54]  D. Barrio,et al.  Cytotoxicity of a vanadyl(IV) complex with a multidentate oxygen donor in osteoblast cell lines in culture. , 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).

[55]  D. Wyrzykowski,et al.  Investigation of Tetrahalogenoferrates(III) with Cations of Nitrogen-Containing Organic Bases. X-ray Crystal Structure of 2,6-Dimethylpyridinium Tetrabromoferrate(III) , 2008 .

[56]  J. McNeill,et al.  Insulin‐like actions of vanadium: Potential as a therapeutic agent , 2003 .

[57]  J. Q. Xu,et al.  Synthesis, Crystal Structure and Magnetism of Vanadium(IV/V) Complex: K3[V2O3(nta)2]ź3H2O , 2001 .

[58]  L. Chmurzyński,et al.  A Potentiometric Study on Proton-Transfer Equilibria and Cationic Conjugation in Pyridine N-Oxide Systems in Acetone and Methanol , 1996 .

[59]  C. Berset,et al.  Use of a Free Radical Method to Evaluate Antioxidant Activity , 1995 .

[60]  K. Hirotsu,et al.  A mixed valence binuclear complex of vanadium(IV) and vanadium(V). X-Ray crystal structure of (NH4)3[V2O3(nitrotriacetate)2]·3H2O , 1979 .